1. Lorenzini, Paolo Alberto, Chew, Resilind Su Ern, Tan, Cheryl Weiqi, Zheng, Jie, Roca, Xavier. 2019. Human PRPF40B regulates hundreds of alternative splicing targets and represses a hypoxia expression signature. In RNA (New York, N.Y.), 25, 905-920. doi:10.1261/rna.069534.118. https://pubmed.ncbi.nlm.nih.gov/31088860/
2. Larsson, Connie A, Cote, Gilbert, Quintás-Cardama, Alfonso. 2013. The changing mutational landscape of acute myeloid leukemia and myelodysplastic syndrome. In Molecular cancer research : MCR, 11, 815-27. doi:10.1158/1541-7786.MCR-12-0695. https://pubmed.ncbi.nlm.nih.gov/23645565/
3. Becerra, Soraya, Montes, Marta, Hernández-Munain, Cristina, Suñé, Carlos. 2015. Prp40 pre-mRNA processing factor 40 homolog B (PRPF40B) associates with SF1 and U2AF65 and modulates alternative pre-mRNA splicing in vivo. In RNA (New York, N.Y.), 21, 438-57. doi:10.1261/rna.047258.114. https://pubmed.ncbi.nlm.nih.gov/25605964/
4. Tan, Cheryl Weiqi, Sim, Donald Yuhui, Zhen, Yashu, Koh, Jace, Roca, Xavier. . PRPF40A induces inclusion of exons in GC-rich regions important for human myeloid cell differentiation. In Nucleic acids research, 52, 8800-8814. doi:10.1093/nar/gkae557. https://pubmed.ncbi.nlm.nih.gov/38943321/
5. Lau, Ching-In, Rowell, Jasmine, Yanez, Diana C, Ono, Masahiro, Crompton, Tessa. 2021. The pioneer transcription factors Foxa1 and Foxa2 regulate alternative RNA splicing during thymocyte positive selection. In Development (Cambridge, England), 148, . doi:10.1242/dev.199754. https://pubmed.ncbi.nlm.nih.gov/34323272/
智鼠故事 
